ABSTRACT
Aging and obesity are primary risk factors for chronic conditions such as hypertension and diabetes. However, a mechanistic correlation between these risk factors has not been fully established. Using a historical birth cohort from Chile, we delve into the relationship between obesity and accelerated aging, spanning cellular to systemic levels. The cohort, comprising men and women in their late 20s, had their BMI recorded since birth, with 57% having obesity since childhood or adolescence. Our aim was to investigate if persistent obesity since childhood or adolescence leads to the display of molecular aging features in young adulthood. We also sought to determine whether cardiometabolic health issues accompanied this early aging phenotype. We used inferential statistics and data mining for analysis. Results show that persistent obesity since childhood or adolescence leads to epigenetic changes, telomere shortening, chronic inflammation, impaired nutrient sensing, mitochondrial stress, and diminished intercellular communication, resembling a compound network of interactions. This obesity-induced accelerated aging phenotype coincided with persistent decline of the cardiometabolic profile. Implications of our findings are significant and suggest that integrating molecular markers with clinical and epidemiological data could be valuable in identifying individuals at increased disease risk due to accelerated aging.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://bmcgeriatr.biomedcentral.com/articles/10.1186/s12877-022-03032-4
Funding Statement
This research was supported by grants from Agencia Nacional de Investigacion y Desarrollo (ANID) (Chile) through Anillos de Investigacion en Ciencia y Tecnologia (ACT210006 to PC, CA, RB, FS, RT, CGB); Fondo Nacional de Investigaciones Cientificas y Tecnologicas (FONDECYT #1210283 to RB, PC); Centro de Gerociencia, Salud Mental y Metabolismo (GERO) (FONDAP #15150012 to CGB, FC, FS). Fundacion MAPFRE (Spain) also provided support through Ayudas a la Investigacion Ignacio H. de Larramendi (MAPFRE-2101 to PC, CA, RB, FS, CGB). The funders had no role in study design, data collection and analysis, data interpretation, decision to publish or preparation of manuscripts from the ObAGE Study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The IRBs of the Institute of Nutrition and Food Technology, University of Chile, obtained ethical approval (resolution date: December 1, 2021; number: 21-037). According to the norms for human experimentation, informed and written consent will be obtained from all individual participants included in the study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Abbreviations
- BAZ
- BMI for age and sex
- BMI
- Body mass index
- CAge
- Chronological age
- CIMTl
- Carotid intima-media thickness (left)
- CMITr
- Carotid intima-media thickness (right)
- DBP
- Diastolic blood pressure
- DNAmTL
- DNA methylation estimated telomere length
- DXA
- Dual-energy X-ray absorptiometry
- FGF21
- Fibroblast growth factor 21
- FM
- Whole body fat mass
- GDF11
- Growth Differentiation Factor 11
- GDF15
- Growth Differentiation Factor 15
- Gli
- Fasting glycemia
- HCA
- Hierarchical clustering analysis
- HDL
- High-density lipoprotein
- HOMA-IR
- Homeostatic Model Assessment -Insulin Resistance
- HOMA-β
- Homeostatic Model Assessment -β cell function
- hs CRP
- High sensitivity C reactive protein
- IL10
- Interleukin 10
- IL2
- Interleukin 2
- IL6
- Interleukin 6
- Ins
- Fasting insulin
- MetS
- Metabolic Syndrome
- NAFLD
- Non-alcoholic fatty liver disease
- NCDs
- Non-communicable chronic diseases
- OCA
- Obesity since childhood or adolescence
- PWV
- Pulse wave velocity
- SBP
- Systolic blood pressure
- SPISE
- Single-point insulin sensitivity estimator
- T2D
- Type-2 diabetes
- TG
- Fasting triglycerides
- TNAα
- Tumoral Necrosis Factor α
- VAT
- Visceral adipose tissue
- WC
- Waist circumference
- WtHtR
- Waist-to-height ratio
